Post-partum hemorrhage complicated by reverse-Takotsubo cardiogenic shock; a novel therapeutic approach

Am J Emerg Med. 2017 Jun;35(6):935.e1-935.e3. doi: 10.1016/j.ajem.2016.12.034. Epub 2016 Dec 19.

Abstract

Takotsubo Cardiomyopathy (TTC) is a type of transient, yet severe left ventricular systolic dysfunction, rarely complicating extreme emotional stress ("primary" TTC) or critical medical/surgical illness ("secondary" TTC forms). Although usually reversible, TTC may result in cardiogenic shock with dismal prognosis. "Secondary" TTC forms are particularly in danger for this complication, bearing significantly worse short and long-term prognosis. Herein, we report a rare case of a life-threatening "secondary" TTC in a patient with post-cesarean section severe hemorrhage, and we point out that early co-administration of esmolol and levosimendan might be an effective and safe therapeutic approach in "reversing" TTC-induced cardiogenic shock, especially when invasive therapeutic strategies are practically unfeasible.

Keywords: Cardiogenic shock; Esmolol; Levosimendan; Management; Pathophysiology-based; Reverse Takotsubo cardiomyopathy.

Publication types

  • Case Reports
  • Video-Audio Media

MeSH terms

  • Adrenergic beta-1 Receptor Antagonists / therapeutic use
  • Adult
  • Cesarean Section / adverse effects*
  • Echocardiography
  • Female
  • Humans
  • Postoperative Complications
  • Postpartum Hemorrhage / etiology
  • Postpartum Hemorrhage / physiopathology*
  • Postpartum Period
  • Pregnancy
  • Prognosis
  • Propanolamines / therapeutic use
  • Shock, Cardiogenic / etiology
  • Takotsubo Cardiomyopathy / diagnostic imaging*
  • Takotsubo Cardiomyopathy / drug therapy*
  • Takotsubo Cardiomyopathy / etiology
  • Ventricular Function, Left / drug effects

Substances

  • Adrenergic beta-1 Receptor Antagonists
  • Propanolamines
  • esmolol